logo

Last Update

This profile was last updated on 10/15/2001 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Robert Dinerstein?

Robert J. Dinerstein

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Background Information

Employment History

Senior Research Scientist

Aventis SA


Assistant Professor

University of Chicago Department of Pharmacological and Physiological Sciences


Senior Research Scientist In the Respiratory and Rheumatoid Arthritis Disease Group

Aventis DI&A


Hoechst Marion Roussel , Inc.


Web References(5 Total References)


TurboWorx, Inc. - Press / News

www.turbogenomics.com [cached]

-ROBERT DINERSTEIN, SENIOR RESEARCH SCIENTIST, AVENTIS PHARMA "It's a magical time in the history of science now that we have so much computing power and storage capacity," says Robert Dinerstein, a senior research scientist in the Bridgewater, N.J., laboratories of Frankfurt, Germany-based Aventis Pharma. "Some idea got us started-either from scientific literature, a particular researcher's expertise or just someone's crazy idea," Dinerstein explains."We're an information-based industry, but we've been a bit behind in the extent to which we've been using computer-based tools," Dinerstein says."Everyone has different databases," says Dinerstein of Aventis, which was formed by the merger of Hoechst Marion Roussel with Rhone-Poulenc Rorer in 1999.PHOTO CREDITS: ROBERT DINERSTEIN BY PETER VIDOR; RICK ROBERTS BY PETER GLASS; PETER LOUPOS BY PETER VIDOR; KEN FASMAN BY MARK ALCAREZ


Entelos News

www.entelos.com [cached]

The presentation will be jointly delivered by Thomas S. Paterson, Chief Scientific Officer of Entelos, and Robert J. Dinerstein, M.D., Ph.D., Senior Research Scientist of Aventis Pharma.
Paterson and Dinerstein will be discussing the asthma PhysioLab, the principles and components of its design, and why the use of modeling and simulation systems are a critical next step for the drug industry. Dr. Robert Dinerstein is a senior research scientist in the Respiratory Diseases Group at Aventis Pharma. Prior to joining Hoechst Marion Roussel, a predecessor of the Aventis organization, in 1985, Dr. Dinerstein held the position of assistant professor at the University of Chicago Department of Pharmacological and Physiological Sciences. He completed his Ph.D. in Organic Chemistry at the University of Oregon, and earned his M.D. at the University of Chicago.


AVENTIS > Robert Dinerstein - Computer-Assisted Drug Design

www2.aventis.com [cached]

Robert Dinerstein - Computer-Assisted Drug DesignRobert Dinerstein, MD, Ph.D. is a Senior Research Scientist in the Respiratory/Rheumatoid Arthritis Disease Group at Aventis DI&A in Bridgewater, NJ. In this Point of View, he discusses the use of computer-assisted tools and technologies, and their impact on the drug discovery process.


Entelos Press Release

www.entelos.com [cached]

The presentation will be jointly delivered by Thomas S. Paterson, Chief Scientific Officer of Entelos, and Robert J. Dinerstein, M.D., Ph.D., Senior Research Scientist of Aventis Pharma. Paterson and Dinerstein will be discussing the asthma PhysioLab, the principles and components of its design, and why the use of modeling and simulation systems are a critical next step for the drug industry.Dr. Robert Dinerstein is a senior research scientist in the Respiratory Diseases Group at Aventis Pharma.Prior to joining Hoechst Marion Roussel, a predecessor of the Aventis organization, in 1985, Dr. Dinerstein held the position of assistant professor at the University of Chicago Department of Pharmacological and Physiological Sciences.He completed his Ph.D. in Organic Chemistry at the University of Oregon, and earned his M.D. at the University of Chicago.


DiabetesWebSite - News Details

www.diabeteswebsite.com [cached]

The presentation will be jointly delivered by Thomas S. Paterson, Chief Scientific Officer of Entelos, and Robert J. Dinerstein, M.D., Ph.D., Senior Research Scientist of Aventis Pharma.Paterson and Dinerstein will be discussing the asthma PhysioLab, the principles and components of its design, and why the use of modeling and simulation systems are a critical next step for the drug industry.Dr. Robert Dinerstein is a senior research scientist in the Respiratory Diseases Group at Aventis Pharma.Prior to joining Hoechst Marion Roussel, a predecessor of the Aventis organization, in 1985, Dr. Dinerstein held the position of assistant professor at the University of Chicago Department of Pharmacological and Physiological Sciences.He completed his Ph.D. in Organic Chemistry at the University of Oregon, and earned his M.D. at the University of Chicago.Entelos, Inc. (http : //www.entelos.com), headquartered in Menlo Park, California, is the commercial leader in virtual research and development systems for the pharmaceutical and biotechnology communities.The company provides predictive biological modeling and disease-simulation systems for drug discovery, development, and commercialization.The company's premier products, PhysioLabs, are rigorous quantitative models of human physiology that provide researchers and clinicians with a new system for testing hypotheses, managing scientific and clinical data, and conducting virtual experiments.Entelos offers PhysioLab subscriptions, a range of professional services, and development partnerships.Entelos Obesity PhysioLab and Entelos Asthma PhysioLab are available today.A diabetes PhysioLab and an adipocytes CytoLab are scheduled for completion this year.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory